Skip to Main Content
Table 1—

Baseline characteristics of diabetic patients by HCV status

CharacteristicsHCV subjectsNon-HCV subjectsP
n* 24 288 — 
Age (years) 55.6 ± 2.0 60.5 ± 0.78 0.078 
Men/women 12 (50)/12 (50) 98 (34.0)/190 (66.0) 0.125 
African American/non–African American 23 (95.8)/1 (4.2) 240 (83.3)/48 (16.7) 0.145 
Duration of diabetes (years) 12.3 ± 1.9 15.3 ± 0.69 0.231 
Diabetic nephropathy as primary renal diagnosis 10 (41.7) 172 (59.7) 0.090 
BMI (kg/m229.9 ± 1.4 33.5 ± 0.47 0.033 
Systolic blood pressure (mmHg) 157.1 ± 4.9 153.8 ± 1.6 0.560 
Diastolic blood pressure 87.3 ± 2.9 81.9 ± 0.80 0.066 
Estimated GFR (ml/min) 46.8 ± 7.8 42.4 ± 1.5 0.426 
High urine protein 11/22 (50) 98/247 (39.7) 0.370 
Number of blood pressure medications 2.67 ± 0.26 2.53 ± 0.09 0.670 
On renin angiotensin system inhibitor 11/19 (57.9) 122/193 (63.2) 0.630 
Cardiovascular disease 11 (45.8) 142 (50.7) 0.676 
Extrarenal microvascular complications 9 (37.5) 113 (39.2) 0.99 
CharacteristicsHCV subjectsNon-HCV subjectsP
n* 24 288 — 
Age (years) 55.6 ± 2.0 60.5 ± 0.78 0.078 
Men/women 12 (50)/12 (50) 98 (34.0)/190 (66.0) 0.125 
African American/non–African American 23 (95.8)/1 (4.2) 240 (83.3)/48 (16.7) 0.145 
Duration of diabetes (years) 12.3 ± 1.9 15.3 ± 0.69 0.231 
Diabetic nephropathy as primary renal diagnosis 10 (41.7) 172 (59.7) 0.090 
BMI (kg/m229.9 ± 1.4 33.5 ± 0.47 0.033 
Systolic blood pressure (mmHg) 157.1 ± 4.9 153.8 ± 1.6 0.560 
Diastolic blood pressure 87.3 ± 2.9 81.9 ± 0.80 0.066 
Estimated GFR (ml/min) 46.8 ± 7.8 42.4 ± 1.5 0.426 
High urine protein 11/22 (50) 98/247 (39.7) 0.370 
Number of blood pressure medications 2.67 ± 0.26 2.53 ± 0.09 0.670 
On renin angiotensin system inhibitor 11/19 (57.9) 122/193 (63.2) 0.630 
Cardiovascular disease 11 (45.8) 142 (50.7) 0.676 
Extrarenal microvascular complications 9 (37.5) 113 (39.2) 0.99 

Data are means ± SE or n (%).

*

In some cases the n for a variable is not equal to the total N.

Close Modal

or Create an Account

Close Modal
Close Modal